Please provide your email address to receive an email when new articles are posted on . Twelve years ago at the AECOS meeting, a program chair asked the audience if in 10 years we would be able to ...
Please provide your email address to receive an email when new articles are posted on . The first FDA-approved presbyopia-correcting IOL entered the U.S. market in 1997 when the Allergan Medical ...
Latest addition to Alcon’s intraocular lens (IOL) portfolio expands surgeons’ presbyopia-correcting IOL (PC-IOL) offerings Vivity X-WAVE technology delivers extended range of vision while maintaining ...
GENEVA--(BUSINESS WIRE)-- Regulatory News: Alcon (SIX/NYSE:ALC), the global leader in eye care announced AcrySof® IQ Vivity®, a first-of-its-kind intraocular lens (IOL) is now commercially available ...
As a result of the work of five years of research, they have created the first trifocal corneal inlay that is also fully transparent. Such an inlay would allow good eyesight to presbyopic people of ...
A team from the Universitat Politècnica de València (UPV), the Universitat de València (UV) and the Aiken Ophthalmic Clinic (through its Research Foundation) have designed and assessed in their ...
“We are excited to introduce Vivity because it addresses some common concerns of surgeons and cataract patients alike when considering presbyopia-correcting IOLs (PC-IOLs),” said Michael Onuscheck, ...
GENEVA--(BUSINESS WIRE)-- Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, has commercially launched the first and only non-diffractive extended depth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results